Back to Executive Profile
Alpha

Alpha Profiles · Executive Profile

Benjamin Hohl

Chief Financial Officer and Head of Corporate Development at Enliven Therapeutics, Inc. (NASDAQ: ELVN)

https://registry.alpha.ac/people/benjamin-hohl

BH

Generated 2026-11-18T01:15:14.284Z

Data as of 2026-11-18T01:15:13.956445+00:00

https://registry.alpha.ac/people/benjamin-hohl